Bath & Body Works Must Prove Body Care Has Stopped Bleeding or Admit the Turnaround Stalled
Bath & Body Works (BBWI) reports fiscal Q2 2027 earnings before the open on August 26, 2026, with analysts expecting $0.24 per share—a sharp 35% decline from the prior-year quarter. The central question: can the specialty retailer stabilize sales and margins after a challenging year marked by declining traffic and promotional pressure, or will the downward trajectory continue? With the stock trading below all major moving averages and technical signals flashing caution, this report will test whether management's turnaround efforts are gaining traction.
Part 1: Earnings Preview
Bath & Body Works operates over 1,800 specialty retail stores across North America, selling personal care and home fragrance products under its flagship brand. The company generates the majority of its revenue from body care, soaps, and candles sold through its mall-based stores and direct channels.
BBWI is scheduled to report fiscal Q2 2027 results before the market opens on August 26, 2026. The consensus estimate stands at $0.24 per share on revenue of approximately $1.49 billion. In the most recent quarter (Q1 fiscal 2027), the company reported $0.32 per share, beating the $0.29 estimate by 10.34% on revenue of $1.38 billion.
Compared to the same quarter last year, when BBWI earned $0.37 per share, the current estimate of $0.24 represents a 35% year-over-year decline—reflecting the ongoing headwinds facing the business. Management has guided for Q2 net sales to decline 3% to 5% and EPS of $0.20 to $0.25, with the consensus sitting at the high end of that range.
Three key themes define this earnings story:
Traffic and Conversion Pressure: The core challenge remains driving customers into stores and converting visits into sales. Comparable store sales have been negative, and management acknowledged in the Q1 call that results "remain below the brand's potential." Investors will scrutinize whether promotional activity and new product launches are stabilizing traffic trends or if the decline is accelerating.
Margin Defense in a Promotional Environment: With the broader retail landscape increasingly promotional, BBWI faces pressure to maintain pricing power while competing for wallet share. The company's ability to protect gross margins while investing in marketing and store experience will be critical to demonstrating operating leverage.
Full-Year Guidance Credibility: Management reaffirmed full-year fiscal 2027 guidance of net sales down 4.5% to 2.5% and adjusted EPS of $2.40 to $2.65. With consensus at $2.63, investors need to see evidence that the second half can deliver the acceleration required to hit these targets—particularly given the challenging Q2 setup.
Analyst commentary heading into the release is cautious. Goldman Sachs downgraded the stock to Sell in July, cutting its price target to $19 and citing concerns about the promotional environment. Meanwhile, JPMorgan and Jefferies have maintained neutral stances with targets in the $22–$24 range, suggesting limited upside until the business inflects. The consensus rating of 3.33 (Hold) reflects skepticism that near-term catalysts can offset structural headwinds.
Part 2: Historical Earnings Performance
BBWI has delivered a mixed earnings track record over the past four quarters, with two beats and one significant miss. The company beat estimates in Q1 fiscal 2027 ($0.32 vs. $0.29) and Q4 fiscal 2026 ($2.05 vs. $1.77, a strong 15.82% surprise), but missed badly in Q3 fiscal 2026 ($0.35 vs. $0.40, down 12.50%). The Q2 fiscal 2026 result matched estimates exactly at $0.37.
The pattern reveals volatility in execution, with the holiday quarter (Q4) delivering a meaningful upside surprise while the back-to-school period (Q3) disappointed. The most recent quarter's 10.34% beat suggests some stabilization, but the magnitude of beats has been modest outside of the holiday period. Importantly, the year-over-year earnings trajectory is clearly negative—Q1 fiscal 2027's $0.32 was down from $0.49 in the prior year, and the upcoming quarter's $0.24 estimate is down 35% from $0.37.
The inconsistency in results and the sharp year-over-year declines underscore the challenges BBWI faces in navigating a difficult operating environment. Investors should expect continued volatility, with execution risk elevated given the narrow range between the high and low estimates ($0.22 to $0.26) and management's own guidance spanning $0.20 to $0.25.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jul 2025 | $0.37 | $0.37 | unch | Beat |
| Oct 2025 | $0.40 | $0.35 | -12.50% | Miss |
| Jan 2026 | $1.77 | $2.05 | +15.82% | Beat |
| Apr 2026 | $0.29 | $0.32 | +10.34% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
BBWI typically reports earnings before the market open, meaning Day 0 captures the first full trading session reaction and Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-27 | +$1.72 (+9.70%) | $1.70 (9.59%) | +$0.91 (+4.68%) | $1.16 (5.99%) |
| 2026-03-04 | +$0.58 (+2.59%) | $2.13 (9.47%) | -$0.72 (-3.13%) | $1.69 (7.34%) |
| 2025-11-20 | -$5.22 (-24.81%) | $1.11 (5.25%) | -$0.97 (-6.13%) | $1.28 (8.06%) |
| 2025-08-28 | -$2.18 (-6.91%) | $1.92 (6.09%) | -$0.15 (-0.51%) | $0.74 (2.54%) |
| 2025-05-29 | -$1.90 (-6.23%) | $3.22 (10.56%) | -$0.46 (-1.61%) | $0.88 (3.08%) |
| 2025-02-27 | -$5.22 (-12.71%) | $2.68 (6.52%) | +$0.37 (+1.03%) | $2.17 (6.05%) |
| 2024-11-25 | +$5.07 (+16.51%) | $2.73 (8.89%) | -$0.55 (-1.54%) | $1.30 (3.63%) |
| 2024-08-28 | -$2.43 (-7.00%) | $2.55 (7.34%) | -$1.29 (-4.00%) | $1.79 (5.53%) |
| Avg Abs Move | 10.81% | 7.97% | 2.83% | 5.28% |
BBWI exhibits high volatility around earnings, with an average absolute Day 0 move of 10.81% and an average Day 0 range of 7.97%. The most recent report (May 2026) saw the stock surge 9.70% on Day 0 following the Q1 beat, with continued strength into Day +1 (+4.68%). However, the prior three reports were all negative on Day 0, including a brutal 24.81% plunge in November 2025 and double-digit declines in February 2025 (down 12.71%) and August 2024 (down 7.00%).
The Day +1 follow-through averages 2.83%, suggesting that initial reactions tend to moderate but directional momentum often persists into the second session. The 5.28% average Day +1 range indicates continued elevated volatility beyond the immediate reaction. Given the stock's recent pattern of sharp moves in both directions, investors should prepare for significant price swings—particularly if results or guidance deviate materially from expectations.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/28/26 (DTE 3) |
| Expected Move | $1.88 (10.69%) |
| Expected Range | $15.70 to $19.46 |
| Implied Volatility | 172.35% |
The options market is pricing an expected move of 10.69% (±$1.88) through the August 28 weekly expiration, closely aligned with the 10.81% average historical Day 0 move. This suggests options traders are anticipating volatility consistent with BBWI's recent earnings behavior, with no unusual premium or discount to historical norms.
Part 3: What Analysts Are Saying
Analysts maintain a cautious stance on BBWI heading into earnings, with a consensus rating of 3.33 (Hold) and an average price target of $23.00. The current breakdown shows 4 Strong Buys, 13 Holds, and 1 Strong Sell among 18 analysts covering the stock. The mean target of $23.00 implies 31% upside from the current price of $17.58, though the wide range of targets ($19 to $30) reflects significant disagreement about the stock's prospects.
Sentiment has improved over the past month, with one analyst upgrading from Hold to Strong Buy, pushing the Strong Buy count from 3 to 4. However, the overwhelming Hold consensus (13 of 18 ratings) signals that most analysts are taking a wait-and-see approach, unwilling to recommend aggressive positioning until the business demonstrates sustained improvement.
The $23.00 consensus target sits well above the current price but below the stock's 52-week high of $32.32, suggesting analysts see recovery potential but remain skeptical of a full rebound to prior levels. The single Strong Sell rating (Goldman Sachs at $19) represents the bear case that promotional pressure and traffic declines will persist, while the $30 high target reflects the bull case that the brand can stabilize and return to growth. The clustering of targets in the low-$20s range indicates most analysts expect modest upside contingent on execution and guidance.
Part 4: Technical Picture
BBWI enters earnings in a deteriorating technical position, with the stock trading at $17.58—below all six major moving averages. The Barchart Technical Opinion currently reads 40% Sell, a significant weakening from 24% Buy one month ago and 16% Sell one week ago. This rapid shift lower reflects mounting selling pressure as the stock has broken down through key support levels.
Timeframe Analysis:
- Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative heading into the report
- Medium-term (50% Buy): Conflicting buy signal suggests some intermediate-term support remains, though weakening
- Long-term (100% Sell): Strong sell signal reflects significant weakness in the longer-term trend, with the stock well off its highs
Trend Characteristics: The combination of Weak strength and Average direction suggests the stock is in a choppy, directionless pattern with limited conviction in either direction—an unstable setup heading into a high-volatility event.
The stock is trading below the 5-day moving average ($19.10), below the 10-day ($19.05), below the 20-day ($19.59), below the 50-day ($20.35), below the 100-day ($19.49), and below the 200-day ($20.18). This complete breakdown below all moving averages is a bearish configuration, with the nearest resistance at the 10-day around $19.05 and stronger resistance at the 50-day near $20.35.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $19.10 | 50-Day MA | $20.35 |
| 10-Day MA | $19.05 | 100-Day MA | $19.49 |
| 20-Day MA | $19.59 | 200-Day MA | $20.18 |
The technical setup is cautionary heading into earnings, with the stock in a clear downtrend and no meaningful support visible until the $15.70 level implied by the options expected move. The 100% Sell reading on the long-term timeframe and positioning below all moving averages suggest the path of least resistance is lower absent a significant positive surprise. Bulls need to see the stock reclaim the $19–$20 zone to stabilize the technical picture, while bears have momentum on their side. Given the 10.69% expected move and the stock's history of sharp post-earnings swings, risk management is critical—this setup favors waiting for the dust to settle rather than taking directional bets into the print.